Latest / The Acquisition Talk with Fexingo: Mergers, Buyouts, and Business Sales for Operators / How Private Equity Turns Cash Flow Into Debt
Transcript
- Lucas: We’ve spent the last few episodes talking about what happens after the ink dries on a deal—integration playbooks, cultural fit, talent retention. But there’s a quieter, more mechanical shift that often happens before the closing even fully settles: the way private equity firms restructure the cash flow of their new assets. Specifically, I want to talk about how they use supply chain finance to turn accounts payable into a form of short-term debt. Luna: You mean those reverse factoring programs where the big buyer gets a bank to pay suppliers early, but at a rate tied to the buyer’s own credit rating? Lucas: Exactly. It’s elegant because it looks like free money for the supplier—they get paid faster than the standard net sixty or ninety terms—but the cost is baked into the invoice. And since the interest rate is based on the private equity firm’s strong balance sheet, not the supplier’s weaker one, the supplier gets a better rate than they would from a traditional line of credit. So everyone smiles, right? Luna: Except the buyer hasn’t actually extended their payment terms. They’re just shifting the financing burden onto the supply chain while keeping their own days payable outstanding exactly where it was. Lucas: Right, and that’s the key distinction. In a traditional scenario, if you wanted to improve your cash conversion cycle, you’d push vendors to accept net forty-five instead of net ninety. That creates friction. It strains relationships. But with supply chain finance, you keep the ninety-day term on paper, so the supplier doesn’t feel the squeeze, but you still optimize your working capital metrics by having the bank pay out early. The buyer’s treasury department loves it because it boosts free cash flow without touching operational contracts. Luna: So it’s basically financial engineering disguised as vendor support. Does the supplier really win here though? Or are they just accepting lower margins to access cheap capital? Lucas: That’s the tension. On the surface, yes, they get cheaper capital. If a small manufacturer can borrow at seven percent from a local bank but gets offered three percent through the PE firm’s program, that’s an immediate margin boost. But it comes with a hidden dependency. Once a supplier opts into the program, they become locked into the buyer’s financial ecosystem. If the PE firm decides to exit or refinance, or if the bank changes its risk appetite overnight, that liquidity tap can vanish instantly. Luna: Which means the supplier’s working capital stability is now tied to the buyer’s corporate actions rather than their own sales performance. Lucas: Precisely. And we’re seeing this accelerate in late 2026. As interest rates remain sticky in the mid-to-high four percent range, private equity sponsors are under pressure to show improved EBITDA margins during their holding period. One of the easiest levers to pull isn’t cutting costs or raising prices—it’s extracting value from the supply base through these structured finance tools. It’s subtle because it doesn’t appear on the income statement as an expense; it appears as a reduction in working capital requirements, which directly inflates free cash flow. Luna: But doesn’t that create a moral hazard? If the buyer knows they can offload financing costs onto suppliers via the bank, why would they ever negotiate harder on actual product pricing? Lucas: It absolutely disincentivizes price negotiation. I spoke with a CFO of a mid-market industrial distributor who told me their new PE owners rolled out a supply chain finance program within six months of acquisition. Within a year, they had reduced their average inventory days by twelve percent and extended their days payable outstanding by twenty-two percent, all without asking a single vendor to change their contract. The vendor got paid in thirty days instead of fifty-two, but the cost of that early payment was deducted from the invoice amount. The buyer kept the cash longer, effectively getting an interest-free loan for the remaining twenty-two days, while the supplier absorbed the financing cost. Luna: So the buyer is essentially arbitraging the difference between their own low borrowing costs and the supplier’s need for liquidity. It’s a zero-sum game wrapped in a win-win headline. Lucas: And the real danger emerges when you scale this across a large supply base. Let’s say a PE firm owns a portfolio company with two hundred suppliers. If half of them opt into the program, that might represent fifty million dollars in annual spend. At a three percent spread, that’s a million and a half dollars in implicit financing cost shifted to vendors. For the PE firm, that’s pure margin expansion. For the supplier, it’s a slow bleed that makes it harder to invest in R&D or capacity upgrades. Luna: Do suppliers have any leverage to resist this? Or does opting out just mean you lose business to competitors who will accept the program? Lucas: That’s the trap. In many industries, especially fragmented manufacturing or logistics, the power dynamic has tilted heavily toward the buyer. If you refuse to join the approved payer program, you’re stuck with net ninety terms. Most small businesses simply cannot wait ninety days for payment without taking on expensive short-term debt anyway. So they join the program, accept the slightly better rate, and continue to operate on thinner margins. Over time, this erodes their ability to grow organically. Luna: It reminds me of how healthcare providers were squeezed by insurance reimbursement delays. Now the supply chain is facing similar structural pressure. Lucas: A good analogy. The difference is that in healthcare, the payer is often a government entity or a massive insurer with regulatory oversight. In B2B supply chains, it’s purely contractual. And unlike healthcare, where claims are standardized, supply chain finance terms can vary wildly from vendor to vendor. Some buyers offer dynamic discounting, where the supplier chooses the discount rate based on how early they want payment. Others lock them into fixed rates. It’s a messy landscape. Luna: So how do operators spot this when they’re evaluating a potential acquisition target? Is it easy to see in the financials? Lucas: It’s visible, but often misinterpreted. You look at the balance sheet. If you see a spike in 'short-term borrowings' alongside a drop in 'accounts payable,' that’s a classic sign. The company has moved liabilities off the operating account and onto a revolving credit facility or a supply chain finance platform. Alternatively, check the cash flow statement. If operating cash flow improves dramatically without a corresponding increase in sales or EBITDA, dig into the working capital notes. Often, you’ll find a footnote about 'optimized supply chain financing arrangements.' Luna: But wouldn’t that improvement in cash flow look good to a buyer? Like, isn’t that the whole point of buying these companies—to make them more efficient? Lucas: It looks good on paper, yes. But it’s not sustainable operational efficiency. It’s financial restructuring. If you’re buying a company for its growth potential, you don’t want to be overpaying for cash flow that was extracted by squeezing suppliers. That kind of cash flow is fragile. If the supply chain revolts, or if banks tighten lending standards, that liquidity evaporates. Meanwhile, the underlying business operations haven’t changed. The product quality hasn’t improved. The customer base hasn’t grown. You’ve just rearranged the deck chairs. Luna: So the risk is that the buyer assumes this cash flow is organic when it’s actually dependent on continued supplier compliance and favorable banking conditions. Lucas: Exactly. And there’s a secondary risk: reputational. Suppliers are talking. If word gets out that a major buyer is using aggressive supply chain finance to extract value, other vendors may start negotiating harder terms or diversifying away from that buyer. We’ve seen cases where key component suppliers quietly raised prices or delayed shipments because they realized they were being financially exploited. It’s a slow-burn relationship risk. Luna: I wonder if this trend is going to backfire as more suppliers realize they’re paying for the buyer’s luxury. Have you seen any pushback? Lucas: There is some. Larger, more sophisticated suppliers are starting to bundle supply chain finance participation with volume commitments. They’ll say, 'We’ll join your program, but only if you guarantee us fifteen percent of our annual spend.' It’s a counter-negotiation tactic. But for the vast majority of small and mid-sized enterprises, they don’t have the bargaining power to demand guarantees. They take the program because they need the cash. Luna: It feels like a classic principal-agent problem. The treasury team gets bonuses for improving working capital metrics, while the procurement team deals with the fallout of strained vendor relationships later. Lucas: Spot on. The incentives are misaligned. Treasury is measured on quarterly cash flow targets. Procurement is measured on long-term supply stability. When PE firms push hard for supply chain finance, they’re prioritizing the former at the expense of the latter. And in today’s environment, where global supply chains are already fragile due to geopolitical tensions and labor shortages, undermining supplier loyalty is a dangerous gamble. Luna: So for operators listening, the takeaway is to be skeptical of sudden improvements in working capital that don’t come from operational fixes. Ask who is paying for that efficiency. Lucas: Yes. And if you’re the one implementing these programs, remember that trust is a finite resource. Once you burn it by treating your supply base as a financing vehicle rather than a partnership, you may find it hard to rebuild. Especially when the next recession hits and everyone needs favors. Luna: This conversation has been incredibly useful for anyone looking at deal structures beyond just the top-line valuation. If these conversations have moved your work forward in some small way, consider supporting the show directly. You can find us at buy me a coffee dot com slash fexingo — that's F. E. X. I. N. G. O. It helps keep these deep dives ad-free and allows us to spend more time investigating the mechanics behind the headlines. Lucas: Thanks for the support, Luna. It really does make a difference in the quality of research we can do. Before we go, let’s circle back to one final thought on this topic. When we think about value creation in private equity, we usually focus on revenue growth or cost cutting. But supply chain finance reminds us that sometimes the most significant value moves happen in the background, in the plumbing of the balance sheet. Luna: And as always, the question is whether that value is durable or just a temporary accounting illusion. Lucas: Precisely. If the cash flow isn’t backed by real operational improvement, it’s just financial sleight of hand. And in the end, the market always sees through the trick. Thanks for listening.